This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/bindingdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02226/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02226
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02226 n8:DB02226
dcterms:title
3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium
adms:identifier
n10:4451459 n11:DB02226 n12:50271838 n13:46505020 n14:TZ4 n15:5289507
n3:IUPAC-Name
n4:271B4983-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4989-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4988-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4985-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4986-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4987-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4981-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4982-363D-11E5-9242-09173F13E4C5 n4:271B497F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4980-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B498F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4990-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B498A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B498B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B498D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B498C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B498E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4994-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4996-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4997-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4993-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4992-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4995-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4984-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4991-363D-11E5-9242-09173F13E4C5